Kilitch Drugs India, an injectable manufacturer, has commenced production of the Cephalosporin injectables at its manufacturing plant in Ethiopia.

The Indian pharma solution company had launched its greenfield project in the African country in 2018 to build a world-class injectable manufacturing plant.

Earlier this year, Kilitch Drugs India began the production of antiseptic and disinfectant products for helping in Ethiopia’s battle against the Covid-19 pandemic.

The company said that its Cephalosporin injectables plant will be capable of producing 26.4 million vials per year to meet Ethiopia’s demand for 16 million vials.

Most of the capacity of the plant will be dedicated to Ethiopia via government and other institutes, said Kilitch Drugs India.

Mukund Mehta – Chairman and Managing Director of Kilitch Drugs India said: “Africa always has been our focus market for our products. We have started this manufacturing plant to cater to the African markets directly as there very few injectable manufacturing plants in whole continent and in turn help the people of Africa.

“Also, there is more demand than supply in the Ethiopia so we see that this has good business opportunity.”

  Cephalosporin, Ethiopia, Kilitch Drugs India, Mukund Mehta